Two Sigma Advisers
IDYA icon

Two Sigma Advisers’s IDEAYA Biosciences IDYA Stock Holding History

Two Sigma Advisers’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-266,600
Closed -$5.6M – 2486
2025
Q2 		$5.6M Sell
266,600
-147,000
-36% -$2.82M 0.01% 698
2025
Q1 		$6.77M Sell
413,600
-47,000
-10% -$1M 0.02% 666
2024
Q4 		$11.8M Sell
460,600
-7,500
-2% -$212K 0.03% 436
2024
Q3 		$14.8M Buy
468,100
+7,700
+2% +$292K 0.03% 386
2024
Q2 		$16.2M Sell
460,400
-30,900
-6% -$1.22M 0.04% 397
2024
Q1 		$21.6M Buy
491,300
+443,300
+924% +$19.1M 0.05% 325
2023
Q4 		$1.71M Sell
48,000
-88,600
-65% -$2.64M ﹤0.01% 1380
2023
Q3 		$3.69M Sell
136,600
-87,200
-39% -$2.21M 0.01% 888
2023
Q2 		$5.26M Sell
223,800
-58,300
-21% -$1.2M 0.01% 754
2023
Q1 		$3.87M Buy
282,100
+156,500
+125% +$2.61M 0.01% 936
2022
Q4 		$2.28M Buy
125,600
+87,700
+231% +$1.48M 0.01% 1171
2022
Q3 		$565K Sell
37,900
-6,200
-14% -$80.5K ﹤0.01% 1793
2022
Q2 		$609K Sell
44,100
-35,100
-44% -$390K ﹤0.01% 1837
2022
Q1 		$886K Buy
79,200
+67,600
+583% +$996K ﹤0.01% 1695
2021
Q4 		$274K Sell
11,600
-41,100
-78% -$955K ﹤0.01% 2170
2021
Q3 		$1.34M Sell
52,700
-82,800
-61% -$1.93M ﹤0.01% 1474
2021
Q2 		$2.84M Sell
135,500
-74,500
-35% -$1.53M 0.01% 1131
2021
Q1 		$4.93M Sell
210,000
-8,900
-4% -$172K 0.01% 856
2020
Q4 		$3.06M Buy
218,900
+79,400
+57% +$1.08M 0.01% 1051
2020
Q3 		$1.75M Buy
+139,500
New +$1.73M 0.01% 1229

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers's IDYA Position: Q3 2025 in Review

Two Sigma Advisers sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 266,600 shares — an estimated $5.6M sold.

Two Sigma Advisers first reported a position in IDYA in Q3 2020 and held it in 20 quarters. The position peaked at $21.6M in Q1 2024. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Two Sigma Advisers reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 266,600 IDEAYA Biosciences shares in Q3 2025, an estimated $5.6M.
  • Two Sigma Advisers first reported a position in IDEAYA Biosciences in Q3 2020 and held it in 20 quarters.
  • Two Sigma Advisers's IDEAYA Biosciences position peaked at $21.6M in Q1 2024.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.